Generex adds Emmaus CEO to board
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Generex Biotechnology Corp. added Emmaus Life Sciences Inc. Chairman and CEO Yutaka Niihara to its board of directors as executive chairman.
Generex Biotechnology previously signed a letter of intent to acquire a 51% interest in Emmaus.
